TrialJAMA psychiatry2026

Efficacy and Safety of the Neuroplastogen TSND-201 for the Treatment of PTSD: A Randomized Clinical Trial.

Amanda Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.